Product Information
POTASSIUM CITRATE ER 5 MEQ TAB is a generic product labeled by Strides Pharma Inc., priced at $0.1348 per EA under NDC 42543040601. Its NADAC has been published 457 times since Sep 27, 2017.
Strength
5 meq/1
Manufacturer
Strides Pharma Inc.NDC
42543040601
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
POTASSIUM CITRATEApproval Type
Generic (ANDA)
FDA Application
ANDA206813On Market Since
11/1/2017
Pharmacological Classes
Price Statistics
The NADAC for POTASSIUM CITRATE ER 5 MEQ TAB has been published 457 times since Sep 27, 2017, and over the history we have for it it has declined 85.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1348 per EA |
|---|---|
| All-time high | $0.9672 (Nov 15, 2017) |
| All-time low | $0.1064 (May 22, 2024) |
| 52-week high | $0.1499 |
| 52-week low | $0.1217 |
| Median price | $0.4664 |
| Average price | $0.4369 |
| Largest weekly change | +79.1% (Jan 18, 2023) |
| Weeks tracked | 457 |
| Tracking since | Sep 27, 2017 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the POTASSIUM CITRATE market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of POTASSIUM CITRATE ER 5 MEQ TAB?
The current National Average Drug Acquisition Cost (NADAC) for POTASSIUM CITRATE ER 5 MEQ TAB, manufactured by Strides Pharma Inc., is $0.1348 per EA (NDC 42543040601), effective Jun 24, 2026.
How has the price of POTASSIUM CITRATE ER 5 MEQ TAB changed over time?
Over the history we have for it, the NADAC for POTASSIUM CITRATE ER 5 MEQ TAB has declined 85.2%. It has been tracked across 457 weekly CMS publications since Sep 27, 2017.
What are the highest and lowest recorded NADAC prices for POTASSIUM CITRATE ER 5 MEQ TAB?
Since Sep 27, 2017, the NADAC for POTASSIUM CITRATE ER 5 MEQ TAB has ranged from a low of $0.1064 (May 22, 2024) to a high of $0.9672 (Nov 15, 2017), with a median of $0.4664 per EA.
Are there cheaper alternatives to POTASSIUM CITRATE ER 5 MEQ TAB?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of POTASSIUM CITRATE ER 5 MEQ TAB, so no direct lower-cost alternative is listed.
Who manufactures POTASSIUM CITRATE ER 5 MEQ TAB?
POTASSIUM CITRATE ER 5 MEQ TAB (NDC 42543040601) is labeled by Strides Pharma Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification